FT836
FT836-101
Phase 1 small_molecule active
Quick answer
FT836 for Non-Small Cell Lung Cancer is a Phase 1 program (small_molecule) at FATE THERAPEUTICS INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- FATE THERAPEUTICS INC
- Indication
- Non-Small Cell Lung Cancer
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active